1 / 19

Stuart D. Blacksell MPH, PhD, RBP

International Cooperation in Strengthening & Mitigating Biothreats. Stuart D. Blacksell MPH, PhD, RBP Mahidol -Oxford Tropical Medicine Research Unit (MORU), Bangkok, Thailand. Wellcome Trust- Mahosot Hospital-Oxford Tropical Medicine Research Collaboration, Vientiane, Lao PDR.

manasa
Télécharger la présentation

Stuart D. Blacksell MPH, PhD, RBP

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. International Cooperation in Strengthening & Mitigating Biothreats • Stuart D. Blacksell MPH, PhD, RBP • Mahidol-Oxford Tropical Medicine Research Unit (MORU), Bangkok, Thailand. • Wellcome Trust-Mahosot Hospital-Oxford Tropical Medicine Research Collaboration, Vientiane, Lao PDR. • Centre for Tropical Medicine, University of Oxford, United Kingdom.

  2. MORU’s strategic position…. Half of the world’s population within 2000 miles….

  3. MORU – 2011 Bangkok Unit Major field site / laboratory Laos project field site Collaborator’s site Mozambique AQUAMAT collaborative sites Sri Lanka

  4. Diseases driving the needs? • Pandemic emergencies and preparedness (Diagnosis and Research) • Newly Emerging Infections • SARS • Nipah • Agents of increased virulence • Avian/Swine influenza • TB • RG3 Endemic diseases (Diagnosis and research) • Burkholderiapseudomallei • Rickettsia (Orientia tsutsugamushi) • Flaviviruses (Japanese Encephalitis virus)

  5. BSL3 labs in SEA - The MORU experience • BSL3 & BSL2 laboratories • Thailand (4 sites) and Vientiane (Laos) • Cambodia (1), Bangladesh (1) • 2400m2 lab space (Bangkok) • 85 Lab staff (300 total) • Active Biosafety/Biosurity program • NSAR/CDC Select Agent Registered

  6. “BSL3/4 labs” in South East Asia 2 1 1 8 5 1 2 5 13 7

  7. Biocontainment facilities in SEA • At least 45 BSL3 labs in SEA • How many BSL4 or BSL3 Animal? • What standard where the labs built to? • Accredited to any standard? • What is the level of biosafety training? • What is the level of security? • Are the facilities appropriately managed? • Is a BSL3/4 lab really needed? • WHO KNOWS???

  8. Biosafety challenges in SE Asia • Running a Biocontainment facility RESPONSIBLY is a huge investment of time, people, facilities and money. • Most facilities are not properly prepared • Legislation and Standards • Financial • Administrative • Personnel • Logistics • Facilities and Equipment • Enforcement

  9. National legislation • Poorly enforced/Poorly understood • Thailand • Enacted in 2011 • MoPH “licensing” BSL2/3 labs • MORU first BSL3 lab accredited by MoPH • Laos • No legislation • Singapore • Biosafety Act • MOH-Approved Facility Certifier's List /MOH-BSL3 Laboratory Certification Checklist • Malaysia • Biosafety Act • Dual Use potential poorly understood.

  10. International Standards • What standard to meet in SEA? • WHO, CDC, UK, Australian • Develop a regional standard? • National standard? • MORU (Funding imperative) • BMBL 5th Ed (Access to NIH funds) • US Select Agent (Access to NIH funds) • UK (Oxford University) • Thai (Based in Thailand)

  11. Financial and Administrative Issues • Financial • Limited budgets • Maintenance • Training • Corruption! • Administrative • Institutional Biosafety Committee • Incomplete documentation • Biosafety manual • Emergency Response Plan • Interaction with First Responders (Police/Fire) • Standard Operating Procedures

  12. Personnel • Severe lack of Biosafety administrators! • How to deal with this issue? • Training • Institutional • Donors (BEP, Sandia, WHO, AusAID) • Local or overseas • Partnerships • Twinning (Regional partnership – AAHL, MORU) • MORU • Full-time Biosafety Administrator • 50% time Registered Biosafety Professional • 7 Biosafety site representatives

  13. Security/Restricting Access • Site specific security plan • Staff with access • USA • FBI clearance - Restricted person criteria (Criminal, Drugs, Terrorism) • US Dept of Justice registered “entity” personnel • Thailand • Local Police check using national and international databases • Laos • No capability

  14. Training – MORU experience • New staff training – lack of “safety culture” • Robust induction procedure • Documented competency • “Dual use” awareness • Performed by experts in the area (hands on and A/V) • Onsite/Offsite • Consultants, BEP, Sandia, WHO, AusAID • Regular refresher training • Personnel Protective Equipment • Respirator fit tests • Standard Operating Procedures • Spills & emergency procedures • Decontamination • Document all training

  15. Logistics – Infectious inventories • Baseline Inventory established • Agent, source, quantity, use • Audit trail • Checked periodically by RO’s • Quarterly check of inventory, people, security • MORU experience • Freezerworks software • Very labor intensive • 2 people – 24 months – 20,000 samples

  16. Facilities maintenance and testing • Whatever is built must have locally available service! • Maintenance budgets - often overlooked • BSC testing/HEPA testing • NSF49 or other • Urgent need for accredited BSC/filter testers • Role for donors and partners • Routine upgrades and replacements • Money for new labs is simple! • Easy to see where money has been spent • Difficult to get maintenance budgets!

  17. Other considerations • BSL3 Energy costs • Tropical climate • BSL3 single pass air = very expensive and wasteful • Why not recirculation 85% of the air with additional HEPA filtration • Regional training faculties • Biocontainment engineering/Biosafety Officers/Maintenance • Not for profit • Use facilities and experience that is already available locally • Assess the risks • Do we really need a BSL3 lab? • Can we use BSL2 lab with BSL3 practices

  18. Conclusions • Focus areas for biosafety and biocontainment • Regulations and legislation • Biosafety Administration • Assess the risks – do we really need a Rolls Royce? • Training • Biosafety administration • Biosafety practices/PPE • Emergency response • Facilities maintenance and testing/certification • Forward planning for budgets • Appropriate physical security

  19. Thank you

More Related